InvestorNewsBreaks – Pressure BioSciences Inc. (PBIO) Notes Key Academic Publication Validates Platform’s Impact in Clean-Label Functional Foods & Beverages

Pressure BioSciences (OTCQB: PBIO), a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables, and specialty-testing services to the worldwide pharmaceuticals, biotherapeutics, nutraceuticals, cosmeceuticals, agrochemical, food & beverage, cannabis and other industries, is reporting that its UltraShear(TM) Technology platform delivers transformational capabilities that address leading industry and consumer trends in food & beverage markets. The report was published in a high-impact, peer-reviewed scientific journal, confirming that Pressure BioSciences UltraShear (TM) Technology platform delivers unique capabilities for addressing leading industry and consumer trends in food & beverage markets. According to a recent Grand View Research, the global plant-based beverages market was valued at $24.4 billion in 2021 and is projected to reach  a 12.7% compound annual growth rate (“CAGR”) from through 2030 (global plant-based beverage market). The growing demand for plant-based beverages, such as nondairy milk and smoothies, is driven by their health benefits, nutritional properties, and minimization of carbon footprint and environmental impact, making them popular among health-conscious individuals, the large and growing lactose-intolerant population, and the exploding growth in the vegan consumer segment driven by animal welfare and environmental stewardship concerns. “The global plant protein beverage market is expected to grow to an impressive $41 billion by 2027 (MDC Market Report), with the pea protein market alone growing to about $2.9 billion (Pea Protein Market),” said  Pressure Biosciences president and CEO Richard T. Schmacher in the press release. “Armed with these newly published research results on UltraShear’s enabling capabilities, our internationally renowned colleague Professor V.M. ‘Ball’ Balasubramanian and colleagues at The Ohio State University are leading the way in contacting select U.S. and global food and beverage companies, to introduce them to the UltraShear platform, the Ohio State-PBI food industry consortium, and to PBIO for business partnering discussions that could develop into new leadership opportunities in the burgeoning alternative plant-based and ready-to-drink markets.”

To view the full press release, visit

About Pressure BioSciences Inc.

Pressure BioSciences is a global leader in providing innovative, broadly enabling, high-pressure-based solutions for a range of industries, including biotechnology, pharmaceutical, nutraceutical, cosmeceutical and agrochemical, as well as food and beverage manufacturing. The company’s products utilize both constant and alternating pressure. Its patented enabling technology platform — Pressure Cycling Technology (“PCT”) — features alternating cycles of pressure to control biomolecular interactions, such as cell lysis and biomolecule extraction, safely and reproducibly. PCT-based products are beginning to be widely used for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics and counterbioterrorism applications. PBIO has recently expanded its market opportunities with the acquisition of the BaroFold(TM) patented technology platform, allowing the company to enter the biopharma contract services and GMP manufacturing equipment sector. The company has also developed the scalable and high-efficiency pressure-based UltraShear Technology platform, which allows for the creation of stable nanoemulsions of otherwise immiscible fluids. It also allows for the preparation of higher quality, homogenized, extended shelf-life or room-temperature-stable, low-acid liquid foods that cannot be effectively preserved using existing nonthermal technologies. The company’s commitment to innovation and cutting-edge technology has established PBIO as a leader in the high-pressure industry, providing unique and effective solutions to its customers. For more information, visit the company website at

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published:

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office

InvestorWire is part of the InvestorBrandNetwork

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.